ArticleArchives of public health = Archives belges de sante publique2025
Short-term acute outcomes by clinical and socioeconomic characteristics in adults with SARS-CoV-2: a population-based cohort study focused on the first two years of the COVID-19 pandemic.
Article in Archives of public health = Archives belges de sante publique, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe COVID-19 pandemic disproportionately affected vulnerable populations in terms of comorbidity and socioeconomic disadvantage, both between and within countries. This retrospective population-based cohort study is part of the Horizon 2020 ORCHESTRA project, was conducted in the Emilia-Romagna (E-R) Region, and aimed to investigate the risk of hospitalization, disease severity and all-cause mortality during the 30 days following SARS-CoV-2 infection.
methodsAll adult positive cases notified in E-R from 2020 to 2022 were included. Poisson regression with robust standard error was used to estimate risk ratios for the three outcomes, stratified by sex, pandemic period and adjusted for age, citizenship, deprivation index, risk of hospitalization and death score (RHDS), and vaccination status. Data sources were regional healthcare databases. Supplementary analyses considered citizenship in relation to duration of residency in E-R or aggregated in areas of origin.
resultsDuring the first two years of the pandemic 859,653 E-R residents tested positive for SARS-CoV-2 (47.8% males); 9.6% of them were citizens from high migratory pressure countries (HMPCs). The risk of severe outcomes increased steeply with age, especially in males. RHDS predicted worse outcomes in both sexes while vaccination showed a strong protective effect against all outcomes of acute infection (i.e., recent vaccination was 85% more protective against in-hospital severe disease in both sexes). Immigrants from HPMCs, especially females, showed a higher risk of hospitalization and in-hospital severe disease, in particular those who arrived within 5 years ago from the infection (RR for hospitalization = 1.92, 95%CI = 1.76-2.00 for males, and RR = 2.40, 95%CI = 2.23-2.59 for females), whereas the risk of all-cause mortality was lower compared to residents from low migratory pressure countries (LMPCs) that showed a RR for females of 0.73 (95%CI = 0.59-0.90).
conclusionsThe results provided an overall view of course of acute COVID-19 outcomes in E-R and allowed the risk associated with clinical, demographic, and social characteristics to be measured. The findings suggest that, although national and regional public health policies have helped to mitigate the impact of the pandemic in the general population, inequalities in outcomes among persons with comorbidities and social disadvantages remain. Improvements in the appropriateness, effectiveness and equity of public health strategies are needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.